Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Change Problems Dominate During First Year of Design Control Enforcement

This article was originally published in The Silver Sheet

Executive Summary

DESIGN CONTROL DEFICIENCIES appear to be trending downward since enforcement of the requirements began in June 1998; well-documented development plans are key to an effective design project, industry reps say WARNING LETTERS: Contract manufacturer of Gliatech's Adcon-L adhesion control gel placed on import detention; Critical Disposables, Inc. cited by FDA for QS reg deficiencies  

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036041

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel